People Before Patents! Landmark Decision Protects Access To Affordable Drugs
The landmark decision by the Indian Supreme Court in Delhi to uphold India's Patents Act in the face of the seven-year challenge by Swiss pharmaceutical company Novartis is a major victory for patients' access to affordable medicines in developing countries. "The Supreme Court's decision prevents companies from abusing the patent system to get unwarranted patents on existing medicines, to block price-busting generic competition on HIV and other essential medicines." - Leena Menghaney, Doctors Without Borders/Médecins Sans Frontières Access Campaign Manager, India.